Champaign Imaging

Executive Summary

Champaign Imaging is a private medical device company based in Champaign, Illinois, developing a novel MRI neuroimaging platform that addresses critical gaps in brain imaging. Founded in 2015, the company focuses on creating quieter, motion-corrected MRI systems designed specifically for 'hard-to-image' patients—including those with movement disorders, pediatric populations, and claustrophobic individuals who cannot tolerate conventional MRI noise or require sedation. Their single-solution approach integrates advanced noise reduction and real-time motion correction, potentially reducing scan times, improving image quality, and expanding access to neuroimaging for underserved patient groups. The market opportunity is substantial: over 40 million MRI scans are performed annually in the U.S., with up to 15% of patients experiencing anxiety or motion artifacts that compromise diagnostic quality. Champaign Imaging’s technology could reduce the need for sedation, lower operational costs, and increase throughput for imaging centers. While the company remains private and early-stage, its differentiated value proposition positions it for partnerships or acquisitions by larger MRI manufacturers. Key risks include regulatory hurdles (FDA 510(k) clearance) and competition from established players like GE Healthcare, Siemens, and Philips. Nonetheless, if successful, Champaign Imaging could carve a niche in the growing neuroimaging market, estimated to exceed $8 billion by 2028.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) Clearance for Motion-Corrected MRI Software60% success
• Q1 2027Pivotal Clinical Trial Results in Pediatric Neuroimaging50% success
• TBDStrategic Partnership with Major MRI Manufacturer40% success